Dr. Dietrich Klinghardt

 

Founder of the Klinghardt Academy (USA)

Biography

Dr. Klinghardt – Dr. Dietrich Klinghardt M.D., Ph.D., is Founder of the American Academy of Neural Therapy, Medical Director of the Institute of Neurobiology, and lead clinician at the Comprehensive Medical Centre, all located in Bellevue, Washington. He is also Founder of the Institute for Neurobiology (Germany), CYNIK (Switzerland) and the Klinghardt Academy, (USA).  Internationally known for his successful treatment of chronic pain and illness, Dr. Klinghardt combines non-surgical orthopedic medicine with immunology, endocrinology, toxicology, neural therapy, hypnotherapy and energy psychology. Klinghardt studied medicine (1969-1975) and psychology (1975-1979) graduated from Albert-Ludwigs-Univ, Med Fak, Freiburg, Germany,completing his PhD on the involvement of the autonomic nervous system in autoimmune disorders.

Accolades & Achievements

  • Founder of the American Academy of Neural Therapy, Medical Director of the Institute of Neurobiology

  • Founder of the Institute for Neurobiology (Germany), CYNIK (Switzerland) and the Klinghardt Academy, (USA).

  • Lectured at the universities of Illinois, Utah, Freiburg, Adelaide, Capital University (Washington DC) and others, and the medical schools of Geneva and Zurich.

  • Received the Physician of the Year award from the Global Foundation of Integrative Medicine in May 2007

  • Received the 2011 Physician of the Year Award from the International Association of Oral Medicine & Toxicology.

Dietrich Klinghardt – 2019 USPA Presentation

Title: Applied Biophoton Physics for Healing: Unique Light-Based Tools to Diagnose and Treat Illness.

Brief Description:

Radionics has been around for a long time. The mysteries and misinformation surrounding this enigmatic practice are legend. Due a lack of clear cut science or physics within this art and practice has maintained it in obscurity and outright banishment by the orthodox science community as also from the medical industrial complex who perceive it as a threat to their chemical and pharmacological investments. For Radionics to be better understood and successful there must be placed under it a firm grounded in known science paradigm. This presentation does just that. While all of its science is not yet known much of it is.